Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects

European Journal of Endocrinology

Volumn 159, Issue 6, 2008, Pages 675-684

  Sneve, Monica ^a   Figenschau, Y ^a,b   Jorde, R ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE; PLACEBO; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPERPARATHYROIDISM; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OBESITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SKIN DISEASE; TREATMENT DURATION; URINALYSIS; UROGENITAL TRACT DISEASE; WAIST HIP RATIO; WEIGHT CHANGE; WEIGHT REDUCTION; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BODY MASS INDEX; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; VITAMIN D; WEIGHT LOSS; YOUNG ADULT;

EID: 58149337413     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0339     Document Type: Article

References (34)

1. Kopelman PG. Obesity as a medical problem. Nature 2000 404 635-643.
2. Ravussin E & Bogardus C. Energy balance and weight regulation: genetics versus environment. British Journal of Nutrition 2000 83 S17-S20.
3. Drent ML & van der Veen EA. Endocrine aspects of obesity. Netherlands Journal of Medicine 1995 47 127-136.
4. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, Seidel JC & Lips P. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. Journal of Clinical Endocrinology and Metabolism 2005 90 4119-4123.
5. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? British Journal of Nutrition 2003 89 552-572.
6. Hyppönen E & Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006 29 2244-2246.
7. Arunabh S, Pollack S, Yeh J & Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. Journal of Clinical Endocrinology and Metabolism 2003 88 157-161.
8. Kamycheva E, Joakimsen RM & Jorde R. Intakes of calcium and vitamin D predict body mass index in the population of Northern Norway. Journal of Nutrition 2003 133 102-106.
9. Saleh F, Jorde R, Sundsfjord J, Haug E & Figenschau Y. Causes of secondary hyperparathyroidism in a healthy population: the Tromso study. Journal of Bone and Mineral Metabolism 2006 24 58-64.
10. Kamycheva E, Sundsfjord J & Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study. European Journal of Endocrinology 2004 151 167-172.
11. Ni Z, Smogorzewski M & Massry SG. Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology 1994 135 1837-1844.
12. 2+]i) inhibition of lipolysis in human adipocytes. FASEB Journal 2001 15 2527-2529.
13. Zemel MB, Shi H, Greer B, Dirienzo D & Zemel PC. Regulation of adiposity by dietary calcium. FASEB Journal 2000 14 1132-1138.
14. McCarty MF & Thomas CA. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Medical Hypotheses 2003 61 535-542.
15. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, Holick MF, Hollis BW, Lamberg-Allardt C, McGrath J, Norman AW, Scragg R, Whiting SJ, Willett WC & Zittermarm A. The urgent need to recommend an intake of vitamin D that is effective. American Journal of Clinical Nutrition 2007 85 649-650.
16. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T & Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. American Journal of Clinical Nutrition 2006 84 18-28.
17. Beaulieu C, Kestekian R, Havrankova J & Gascon-Barré M. Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes 1993 42 35-43.
18. Andersen LF, Tomten H, Haggerty P, Løvø A & Husivedt B-E. Validation of energy intake estimated from a food frequency questiounnaire: a double labelled water study. European Journal of Clinical Nutrition 2003 57 279-284.
19. Ainsworth BE, Macera CA, Jones DA, Reis JP, Addy CL, Bowles HR & Kohl HW III. Comparison of the 2001 BRFSS and the IPAQ physical activity questionnaires. Medicine and Science in Sports and Exercise 2006 38 1584-1592.
20. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH & Wide L. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance - a prospective randomized double-blind study. Acta Medica Scandinavica 1987 222 361-367.
21. Lind L, Pollare T, Hvarfner A, Lithell H, Sørensen OH & Ljunghall S. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Research 1989 11 141-147.
22. Nilas L & Christiansen C. Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. International Journal of Obesity 1984 8 407-411.
23. Trivedi DP, Doll R & Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomiscd double blind controlled trial. BMJ 2003 326 469-475.
24. Boon N, Hul GB, Sicard A, Kole E, Van Den Berg ER, Viguerie N, Langin D & Saris WHM. The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity 2006 14 1739-1746.
25. Caan B, Neuhouser M, Aragaki A, Lewis CB, Jackson R, LeBoff MS, Margolis KL, Powell L, Uwaifo G, Whitlock E, Wylie-Rosett J & LaCroix A. Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Archives of Internal Medicine 2007 167 893-902.
26. Heaney RP, Davies KM & Barger-Lux MJ. Calcium and weight: clinical studies. Journal of the American College of Nutrition 2002 21 152S-155S.
27. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Progress in Biophysics and Molecular Biology 2006 92 39-48.
28. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. Journal of the American College of Nutrition 2002 21 146S-151S.
29. Shi H, Norman AW, Okamura WH, Sen A & Zemel MB. 1α,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB Journal 2001 15 2751-2753.
30. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007 357 266-281.
31. Bischoff-Ferrari HA, Dietrich T, Orav EJ & Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. American Journal of Medicine 2004 116 634-639.
32. Vieth R, Chan PC & MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. American Journal of Clinical Nutrition 2001 73 288-294.
33. Hathcock JN, Shao A, Vieth R & Heaney R. Risk assessment for vitamin D. American Journal of Clinical Nutrition 2007 85 6-18.
34. Zerwekh JE. The measurement of vitamin D: analytical aspects. Annals of Clinical Biochemistry 2004 41 272-281.